177219-40-8 Usage
General Description
1-Pentanoylamino-cyclopentane carboxylic acid is a chemical compound that consists of a cyclopentane ring with an attached amino group and a pentanoyl group. It is a type of carboxylic acid derivative, which is commonly used in the field of organic chemistry for various synthetic purposes. 1-pentanoylamino-cyclopentane carboxylic may also have potential applications in the pharmaceutical industry for the development of new drugs, as well as in other industrial processes. It is important to handle this chemical with care and follow proper safety protocols, as it may have specific hazards associated with its use. Overall, 1-pentanoylamino-cyclopentane carboxylic acid is a versatile compound with potential implications in various scientific and industrial fields.
Check Digit Verification of cas no
The CAS Registry Mumber 177219-40-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,7,2,1 and 9 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 177219-40:
(8*1)+(7*7)+(6*7)+(5*2)+(4*1)+(3*9)+(2*4)+(1*0)=148
148 % 10 = 8
So 177219-40-8 is a valid CAS Registry Number.
177219-40-8Relevant articles and documents
Design, synthesis and evaluation of novel potent angiotensin II receptor 1 antagonists
Bao, Xiaolu,Zhu, Weibo,Yuan, Weidong,Zhu, Xingbo,Yan, Yijia,Tang, Hesheng,Chen, Zhilong
, p. 115 - 127 (2016/08/01)
A series of new angiotensin II (Ang II) receptor 1 antagonists were designed, synthesized and evaluated. All compounds showed nanomolar affinities for the angiotensin II type 1 receptor in radioligand binding assays and could reduce blood pressure signifi
SYNTHESIS OF 2-BUTYL-3-(2'-(1-TRITYL-1H-TETRAZOL-5-YL)BIPHENYL-4-YL)-1,3-DIAZASPIROL[4,4]-NON-ENE-4-ONE
-
Page 18, (2010/02/08)
Provided is a novel method of making 2-butyl-3-[[2'(1-trityl-1H-tetrazol-5-yl)biphen-4-yl]methyl]1,3-diazaspiro[4,4]non-1-ene-4-one, which can be converted to irbesartan. Also provided are methods of making irbesartan.
Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
-
, (2008/06/13)
The invention relates to the use of an N-substituted heterocyclic derivative and its pharmaceutically acceptable salts for the treatment or prevention of cardiac arrhythmia. These derivatives have the structure STR1